142 related articles for article (PubMed ID: 35752205)
21. Experimental encephalitis caused by Taenia crassiceps cysticerci in mice.
Matos-Silva H; Reciputti BP; Paula EC; Oliveira AL; Moura VB; Vinaud MC; Oliveira MA; Lino-Júnior Rde S
Arq Neuropsiquiatr; 2012 Apr; 70(4):287-92. PubMed ID: 22358311
[TBL] [Abstract][Full Text] [Related]
22. Taenia crassiceps: fatty acids oxidation and alternative energy source in in vitro cysticerci exposed to anthelminthic drugs.
Vinaud MC; Ferreira CS; Lino Junior Rde S; Bezerra JC
Exp Parasitol; 2009 Jul; 122(3):208-11. PubMed ID: 19348802
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.
Gavidia CM; Gonzalez AE; Barron EA; Ninaquispe B; Llamosas M; Verastegui MR; Robinson C; Gilman RH
PLoS Negl Trop Dis; 2010 Feb; 4(2):e616. PubMed ID: 20186332
[TBL] [Abstract][Full Text] [Related]
24. Cysticidal effect of a pure naphthoquinone on Taenia crassiceps cysticerci.
Aranda-López Y; López-López L; Castro KEN; Ponce-Regalado MD; Becerril-Villanueva LE; Girón-Pérez MI; Del Río-Araiza VH; Morales-Montor J
Parasitol Res; 2021 Nov; 120(11):3783-3794. PubMed ID: 34549347
[TBL] [Abstract][Full Text] [Related]
25. Nitazoxanide induces in vitro metabolic acidosis in Taenia crassiceps cysticerci.
Isac E; de A Picanço G; da Costa TL; de Lima NF; de S M M Alves D; Fraga CM; de S Lino Junior R; Vinaud MC
Exp Parasitol; 2016 Dec; 171():17-22. PubMed ID: 27751770
[TBL] [Abstract][Full Text] [Related]
26. Current approaches to cysticidal drug therapy for neurocysticercosis.
Del Brutto OH
Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
[TBL] [Abstract][Full Text] [Related]
27. Experimental neurocysticercosis: absence of IL-4 induces lower encephalitis.
Silva HM; Vinaud MC; Lino RS
Arq Neuropsiquiatr; 2017 Feb; 75(2):96-102. PubMed ID: 28226078
[TBL] [Abstract][Full Text] [Related]
28. A benzimidazole derivative (RCB20) in vitro induces an activation of energetic pathways on Taenia crassiceps (ORF strain) cysticerci.
Fraga CM; da Costa TL; de Castro AM; Reynoso-Ducoing O; Ambrosio J; Hernández-Campos A; Castillo R; Vinaud MC
Exp Parasitol; 2017 Jan; 172():12-17. PubMed ID: 27884580
[TBL] [Abstract][Full Text] [Related]
29. In vivo albendazole treatment of Taenia crassiceps cysticerci strain WFU: proliferation, damage, and recovery.
Zurabian R; Aguilar-Vega L; Terrones Vargas E; Cervera Hernández ME; Willms K; Ruíz-Velasco Acosta S
Parasitol Res; 2013 Nov; 112(11):3961-8. PubMed ID: 24005476
[TBL] [Abstract][Full Text] [Related]
30.
García LCA; Pérez MG; Ancarola ME; Rosenzvit MC; Cucher MA
Parasitology; 2022 Nov; 149(13):1775-1780. PubMed ID: 36165285
[No Abstract] [Full Text] [Related]
31. Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?
Fabbri J; Espinosa JP; Pensel PE; Medici SK; Gamboa GU; Benoit JP; Elissondo MC
Acta Trop; 2020 Jan; 201():105215. PubMed ID: 31600525
[TBL] [Abstract][Full Text] [Related]
32. Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercus antigens obtained by immunoaffinity chromatography.
Espíndola NM; Iha AH; Fernandes I; Takayanagui OM; Machado Ldos R; Livramento JA; Mendes Maia AA; Peralta JM; Vaz AJ
J Clin Microbiol; 2005 Jul; 43(7):3178-84. PubMed ID: 16000432
[TBL] [Abstract][Full Text] [Related]
33. Taenia crassiceps: energetic and respiratory metabolism from cysticerci exposed to praziquantel and albendazole in vitro.
Vinaud MC; Ferreira CS; Lino Junior Rde S; Bezerra JC
Exp Parasitol; 2008 Nov; 120(3):221-6. PubMed ID: 18694746
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
[TBL] [Abstract][Full Text] [Related]
35. Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.
Cangalaya C; Zimic M; Marzal M; González AE; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004207. PubMed ID: 26658257
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy of ivermectin pour-on, albendazole, oxfendazole and fenbendazole against Ostertagia ostertagi inhibited larvae, other gastrointestinal nematodes and lungworm of cattle.
Williams JC; DeRosa A; Nakamura Y; Loyacano AF
Vet Parasitol; 1997 Dec; 73(1-2):73-82. PubMed ID: 9477494
[TBL] [Abstract][Full Text] [Related]
37. Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis.
Singh SK; Prasad KN; Singh AK; Gupta KK; Singh A; Tripathi M; Gupta RK
Exp Parasitol; 2017 Nov; 182():1-8. PubMed ID: 28821422
[TBL] [Abstract][Full Text] [Related]
38. Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci.
Silva LD; Arrúa EC; Pereira DA; Fraga CM; Costa TL; Hemphill A; Salomon CJ; Vinaud MC
Acta Trop; 2016 Sep; 161():100-5. PubMed ID: 27269203
[TBL] [Abstract][Full Text] [Related]
39. A gel-free proteomic analysis of Taenia solium and Taenia crassiceps cysticerci vesicular extracts.
da Costa GCV; Peralta RHS; Kalume DE; Alves ALGM; Peralta JM
Parasitol Res; 2018 Dec; 117(12):3781-3790. PubMed ID: 30215138
[TBL] [Abstract][Full Text] [Related]
40. Differential in vitro effects of insulin on Taenia crassiceps and Taenia solium cysticerci.
Escobedo G; Romano MC; Morales-Montor J
J Helminthol; 2009 Dec; 83(4):403-12. PubMed ID: 19549345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]